Executive Summary: Europe Immunohistochemistry Market

Market Scope: Regional analysis of the European immunohistochemistry (IHC) market covering product categories, clinical/research applications, end-user settings, and country-level performances across key European nations.
Market Valuation: Valued at USD 584.27 million in 2026 and projected to reach USD 1,115.51 million by 2034, registering a steady compound annual growth rate (CAGR) of 7.45% during the forecast period (2026–2034).
Primary Growth Drivers: Rising regional prevalence of cancer and chronic diseases, expanding drug discovery and development activities, and growing adoption of automated diagnostic solutions in pathology laboratories.

Key Market Segment Metrics (2026–2034)

Category	Segments Covered / Product Classes	Key Regional Highlights
By Product	Antibodies, Reagents, Equipment, and Kits	Europe Position: World’s second-leading regional market. Top Country Market: United Kingdom (driven by drug discovery initiatives and chronic disease prevalence). Key Growth Country: Germany (propelled by expanding diagnostic centers and histopathology demand).
By Application	Diagnostics and Drug Testing
By End User	Hospitals, Diagnostic Laboratories, and Research Institutes
By Country	UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic, and Rest of Europe

Major Market Players & Market Structure

Market Structure: Highly competitive diagnostics and life sciences sector dominated by global MedTech leaders competing through technological advancements in automated staining instruments, assay sensitivity, and biomarker discovery.

Key Companies: F. Hoffmann-La Roche AG, Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck Millipore, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Abcam plc, Cell Signaling Technology, Inc., and Bio SB Inc.

Europe Immunohistochemistry Market Size

The Europe immunohistochemistry market size was valued at USD 584.27 million in 2026 and is anticipated to reach USD 627.8 million in 2026 from USD 1,115.51 million by 2034, growing at a CAGR of 7.45% during the forecast period from 2026 to 2034.

Immunohistochemistry is a diagnosis process in which a fresh or stored cancer tissue that is removed out during biopsy is stained. This diagnostic method helps in checking the presence of hormone receptors on the surfaces of cancer cells. Immunohistochemistry is mainly used for the diagnosis of cancers, especially tumor antibodies. It is a vital application in medicine as it helps doctors know the tissue distribution of an antibody.

The developing healthcare infrastructure, rising disposable income, and advancement in medical technology are driving the growth of the Immunotherapy market in Europe. The growing prevalence of cancer actively encourages this region, and various other chronic diseases are also majorly propelling the market growth. Immunohistochemistry has immense popularity in the area of clinical diagnostics, which is used in the diagnosis of chronic diseases such as infectious diseases, cardiovascular diseases, cancer, and autoimmune disorders, and others.

However, huge capital and time requirements and uncertain reimbursement scenarios are significant factors that hamper the growth of this market. Several limitations related to immunohistochemistry techniques and the expensive cost of automated IHC instruments are anticipated to restrains market growth in Europe. Automated immunohistochemistry instruments for disease diagnosis take high setup costs are hindering the market growth.

REGIONAL ANALYSIS

European IHC Market was the world’s second-leading regional market in 2025, and the United Kingdom Immunohistochemistry market was the top-performing regional market in Europe. Factors such as rising drug discovery and development activities and the increasing prevalence of chronic diseases are anticipated to drive the immunohistochemistry (IHC) market growth in the U.K.

The German Immunohistochemistry market shows significant growth due to the rising number of diagnostic centers. Increasing physician awareness and demand for histopathology are anticipated to fuel the growth of this market in the coming years. Additional to this, rapid technological developments in the IVD industry and increasing healthcare expenditure are expected to fuel this market's growth.

KEY MARKET PLAYERS

Promising Companies Operating the Europe Immunohistochemistry Market include

F. Hoffmann-La Roche AG
Danaher Corporation
Agilent Technologies, Inc.
Thermo Fisher Scientific Inc.
Merck Millipore
Bio-Rad Laboratories, Inc.
PerkinElmer, Inc.
Abcam plc
Cell Signaling Technology, Inc.
Bio SB Inc.

MARKET SEGMENTATION

This research report on European Immunohistochemistry Market has been segmented and sub-segmented into the following categories:

By Product

Antibodies
Reagents
Equipment
Kits

By Application

Diagnostics
Drug Testing

By End User

Hospitals
Diagnostic Laboratories
Research Institutes

By Country

UK
France
Spain
Germany
Italy
Russia
Sweden
Denmark
Switzerland
Netherlands
Turkey
Czech Republic
Rest of Europe

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

Europe Immunohistochemistry Market Report